arrow
É

Élizabeth Anderson

university calgary hospital
H指数:43
被引数:8,824

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study

免疫检查点疗法治疗心脏转移患者的安全性与有效性:一项多中心国际回顾性研究

2025-03-031
OA
The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials

抗精神病药物停用或维持治疗对首次发作精神分裂症缓解期患者康复进程的影响——随机对照试验的系统综述与meta分析

2024-01-222
OAAI
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19
2024-01-184
OAAI
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
2024-01-032
OA
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score
2024-01-025
OAAI
Cardiovascular Events After Hematopoietic Stem Cell Transplant Incidence and Risk Factors
2023-12-0112
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (oct, 10.1038/s41591-023-02591-2, 2023)
2023-11-270
OA
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically III Patients With COVID-19
2022-10-0118
OA
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19

可溶性尿激酶型纤溶酶原激活物受体与新型冠状病毒肺炎静脉血栓栓塞症

2022-09-2012
OAAI
Developing an International Standard Set of Patient-Reported Outcome Measures for Psychotic Disorders

制定一套国际标准的精神障碍患者报告结局指标

2022-03-0122
OA
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
2022-01-1942
OA
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
2021-12-2118
OAAI